Search Results
Found 3 results
510(k) Data Aggregation
(230 days)
Ask a specific question about this device
(64 days)
The OsteoProbe is indicated for use as a measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. The device is not intended to diagnose or treat any clinical condition.
OsteoProbe® is a bone microindentation measurement tool. It is a prescription device per 21 CFR Part 801.109. The device includes a single-use disposable component and reusable components. The single-use disposable component has a Spaulding classification of critical and is provided sterile. The reusable components have a Spaulding classification of non-critical and must be reprocessed (cleaning and intermediate-level disinfection) between each use. The device has one accessory: a single-use, disposable sterile cover.
This document is a 510(k) premarket notification for the OsteoProbe device. This type of submission is for establishing substantial equivalence to a legally marketed predicate device, rather than proving novel effectiveness. Therefore, based on the provided document, the device did not undergo a study to prove it meets specific acceptance criteria related to its clinical performance or diagnostic capability.
The document explicitly states: "Clinical testing was not necessary to support equivalence."
The "acceptance criteria" and "device performance" described in the document relate to the physical and material characteristics of the device, primarily to demonstrate substantial equivalence to a predicate device.
Here's an analysis based on the provided text, addressing your questions where possible:
1. Table of acceptance criteria and the reported device performance
Based on the provided document, the "acceptance criteria" and "reported device performance" are primarily related to general device characteristics and safety/manufacturing standards, rather than direct measurements of the device's intended clinical function (measuring bone tissue resistance to microindentation). The document does not provide quantitative performance metrics for the microindentation measurement itself, as clinical testing was not deemed necessary for this 510(k) submission.
Acceptance Criteria Category/Test | Reported Device Performance Summary |
---|---|
Sterilization Validation (AAMI TIR28, ISO 10993-7, & ISO 11135 ) | Validated to ensure the single-use disposable component is sterile. No specific performance metrics (e.g., SAL) are provided, but validation implies meeting relevant standard requirements. |
Distribution Testing (ASTM D4169, ASTM D4332-1 ) | Validated to ensure the device maintains integrity and performance during shipping and handling. No specific performance metrics (e.g., damage rate) are provided. |
Shelf Life (ASTM F1980, ASTM F2096, ASTM F88 ) | Validated to ensure the device remains safe and effective for its intended shelf life. No specific duration or performance metrics (e.g., degradation rate) are provided. |
Biocompatibility (ISO 10993-5, -10, -11 ) | Includes validation for: |
- Cytotoxicity
- Sensitization
- Irritation/Intracutaneous Reactivity
- Acute Systemic Toxicity
- Rabbit Pyrogen-Material Mediated
These tests were conducted to ensure the device materials are safe for patient contact. No specific pass/fail criteria or quantitative results are provided, but completion indicates meeting standard requirements. |
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
No clinical test set was used for clinical performance evaluation as part of this submission. The tests performed (sterilization, distribution, shelf life, biocompatibility) are typically laboratory-based validations. Therefore, this information is not applicable to the provided document.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
Not applicable. No clinical test set or ground truth established by experts for clinical performance was used in this 510(k) submission.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
Not applicable. No clinical test set requiring adjudication was used in this 510(k) submission.
5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
Not applicable. The OsteoProbe is described as a "bone microindentation measurement tool" and is not an AI-assisted diagnostic or imaging interpretation device that would typically involve human readers. No MRMC study was conducted.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
Not applicable. The OsteoProbe is a physical device measuring bone tissue resistance, not an algorithm. Clinical performance studies were not performed for this submission.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
Not applicable. No ground truth for clinical performance was established, as clinical testing was not performed for this 510(k) submission. The "ground truth" for the non-clinical tests (e.g., sterility, biocompatibility) would be defined by the specific standards and their acceptance criteria (e.g., acceptable levels of extractables for biocompatibility, absence of microbial growth for sterility).
8. The sample size for the training set
Not applicable. The OsteoProbe is a physical measurement device, not a machine learning algorithm that requires a training set.
9. How the ground truth for the training set was established
Not applicable. As above, no training set was used.
Ask a specific question about this device
(142 days)
The OsteoProbe is indicated for use as a measurement tool to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of resistance to microindentation is unknown. This device is not intended to diagnose or treat any clinical condition.
The OsteoProbe is a cortical bone microindentation measurement tool based on reference point indenter technology. System hardware consists of a Stylus (1), an Electronics Adapter (2), a Reference Block Holder and single-use Reference Block (3), a single-use disposable Tip Assembly (4), and an Operator Interface (5).
OsteoProbe Acceptance Criteria and Study Summary
The OsteoProbe is a bone indentation device designed to measure bone tissue resistance to microindentation on the tibia in adults. The clinical significance of this measurement is explicitly stated as unknown, and the device is not intended for diagnosis or treatment. The device's acceptance criteria and performance were evaluated through a combination of non-clinical (bench) testing and clinical studies.
1. Acceptance Criteria and Reported Device Performance
The acceptance criteria for the OsteoProbe were established through various tests including packaging adequacy, device performance checks, and detailed performance testing for accuracy and precision.
Acceptance Criteria Category | Specific Criterion | Reported Device Performance |
---|---|---|
Packaging Adequacy (Reusable System) | Average measurement before testing vs. after transport: $73 \pm 1.5$ BMSi | Average measurement before testing was $72.4$ BMSi, and after testing was $73.0$ BMSi. Met. |
% change in strain gage calibration constant after testing: $$(b)(4) logs for microorganisms. | No visible soil seen, hemoglobin and protein testing passed (Hemoglobin $$ (b)(4) logs for (b)(4) and $>$ (b)(4) logs for (b)(4)). Met for all. | |
Shelf Life | Two-year service life verified by accuracy testing after accelerated aging. | Service life of two years was verified. Met. |
Electrical Safety & EMC | Compliance with IEC 60601-1:2005 (Third Edition) + CORR. 1:2006 + CORR. 2:2007 + A1:2012, CAN/CSA-C22.2 No. 60601-1:14IEC 60601-1:2005, and IEC 60601-1-2:2014. | Test results support electrical safety and electromagnetic compatibility. Met. |
Software Reliability | Software documentation reviewed per FDA Guidance (May 11, 2005) for Moderate Level of Concern (includes hazard analysis, requirements, design, traceability, V&V, etc.). | Software documentation was found to be acceptable. Met. |
Strain Gage Sensor Linearity | Sensor linearity (b)(4), average accuracy (b)(4), precision (b)(4) (SD=(b)(4)) over physiological range of indentation depths. | Sensor linearity (b)(4), average accuracy (b)(4), and precision (b)(4) (SD=(b)(4)). Met. |
Device Variability | Device accuracy (b)(4) BMSi units, SD=(b)(4). Point estimate of Device Variability (b)(4) BMSi units (b)(4). | Device accuracy (b)(4) BMSi units, SD=(b)(4). One-way random effects ANOVA point estimate of Device Variability (b)(4) BMSi units (b)(4). Met. |
Operator Variability | Operator accuracy (bias) $ |
Ask a specific question about this device
Page 1 of 1